Breaking News
Get 50% Off 0
🖥️ Intel Earnings: What you need to know
Explore INTC Data
Close

Sarepta Therapeutics Inc (SRPT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Sarepta's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
20.42 -0.22    -1.07%
15:59:59 - Closed. Currency in USD
After Hours
20.40
-0.02
-0.10%
18:00:50 - Real-time Data
  • Volume: 4,948,657
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 18.38 - 20.54
Type:  Equity
Market:  United States
Sarepta 20.42 -0.22 -1.07%

SRPT Recent Sentiments

 
This page features our users' sentiments regarding the Sarepta Therapeutics Inc stock. They are displayed on both charts of different time periods and in a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 22, 2026 Carmine Pugliese   20.83 -1.97%
Apr 17, 2026 Roberto Luccarda   21.27 -4.00%
Apr 16, 2026 Jorge Sierra   21.07 -3.08%
Mar 31, 2026 Rusl mv   21.59 -5.42%
Mar 31, 2026 שאול הראל   21.59 -5.42%
Mar 30, 2026 Tiago Gonçalves   20.04 Mar 30, 2026 @ 20.17 +0.65%
Mar 26, 2026 Peter Barmettler   23.00 Mar 30, 2026 @ 20.17 -12.30%
Mar 26, 2026 Eduardp De Freitas   23.29 Mar 30, 2026 @ 20.17 -13.40%
Mar 25, 2026 Malcolm Metty   23.36 Apr 17, 2026 @ 21.54 -7.79%
Mar 25, 2026 Zohar Shemesh   23.19 Mar 30, 2026 @ 20.17 -13.02%
Mar 25, 2026 عمار وياسين   22.62 Apr 17, 2026 @ 21.54 -4.77%
Mar 25, 2026 Francesco Mariantoni   21.18 Apr 17, 2026 @ 21.54 +1.70%
Mar 23, 2026 Carmine Pugliese   16.81 Mar 23, 2026 @ 17.37 +3.33%
Mar 19, 2026 Oscar Gil   16.55 Mar 26, 2026 @ 23.77 +43.63%
Mar 11, 2026 פרדי איינה   17.09 Apr 03, 2026 @ 23.23 +35.93%
Mar 10, 2026 Vincenzo Canoro   18.10 Apr 03, 2026 @ 23.23 -28.34%
Mar 09, 2026 gabriele compagnone   17.39 Apr 03, 2026 @ 23.23 +33.58%
Mar 06, 2026 Denls dautreme   15.81 Mar 27, 2026 @ 19.97 +26.31%
Mar 03, 2026 chaowan xu   15.89 Mar 27, 2026 @ 19.97 +25.68%
Feb 26, 2026 Francesco Mariantoni   16.77 Mar 20, 2026 @ 16.70 -0.42%
Feb 26, 2026 Roger LaPlante   16.64 Mar 20, 2026 @ 16.70 +0.36%
Feb 26, 2026 Roger LaPlante   16.64 Mar 20, 2026 @ 16.70 +0.36%
Feb 26, 2026 Roger LaPlante   16.64 Mar 20, 2026 @ 16.70 +0.36%
Feb 26, 2026 Roger LaPlante   16.64 Mar 20, 2026 @ 16.70 +0.36%
Feb 25, 2026 Finanzas Públicas   18.90 Mar 20, 2026 @ 16.70 -11.64%
Feb 24, 2026 בני כהן   19.06 Mar 02, 2026 @ 16.25 -14.74%
Feb 24, 2026 İsa Bozkurt   18.93 Mar 20, 2026 @ 16.70 -11.78%
Feb 20, 2026   18.29 Feb 23, 2026 @ 18.19 +0.55%
Feb 18, 2026 Ilan Aviram   18.44 Mar 13, 2026 @ 16.40 +11.06%
Feb 11, 2026 Luca Gabadadze   17.73 Mar 06, 2026 @ 16.71 +5.75%
Feb 05, 2026 gabriele compagnone   17.09 Feb 27, 2026 @ 16.75 -1.99%
Feb 02, 2026 GAETANO RIC   19.75 Feb 09, 2026 @ 18.14 +8.15%
Jan 29, 2026 Gianluca Taini   21.62 Feb 20, 2026 @ 18.88 -12.67%
Jan 26, 2026 chaowan xu   22.61 Feb 20, 2026 @ 18.88 -16.50%
Jan 26, 2026 Isa Isa   22.51 Feb 02, 2026 @ 20.40 -9.37%
Jan 15, 2026   21.74 Feb 06, 2026 @ 18.51 +14.86%
Jan 12, 2026 giulio molinari   20.95 Feb 06, 2026 @ 18.51 -11.65%
Jan 09, 2026 Carmine Alberto   23.08 Jan 12, 2026 @ 21.70 -5.98%
Jan 08, 2026 LUIGI Monti   23.67 Jan 08, 2026 @ 23.54 -0.55%
Jan 07, 2026 Alberto Garcia   22.60 Jan 30, 2026 @ 20.32 -10.09%
Jan 06, 2026 gaetano bazzano   22.26 Jan 09, 2026 @ 23.36 +4.94%
Dec 30, 2025 Nikolay Bozukov   21.56 Jan 23, 2026 @ 21.10 -2.13%
Dec 29, 2025 Pompeyo Curbelo   21.92 Jan 05, 2026 @ 21.43 -2.24%
Dec 26, 2025 chaowan xu   22.05 Jan 16, 2026 @ 21.12 -4.22%
Dec 16, 2025 Simon Zenaty   22.67 Jan 09, 2026 @ 23.83 +5.12%
Dec 10, 2025 Pompeyo Curbelo   21.85 Dec 15, 2025 @ 21.27 -2.65%
Dec 05, 2025 William Campbell   22.50 Dec 26, 2025 @ 22.12 +1.69%
Dec 05, 2025 Stefano Manca   22.00 Dec 08, 2025 @ 21.65 -1.59%
Dec 03, 2025 Julia De Simone   21.89 Dec 26, 2025 @ 22.12 +1.05%
Dec 03, 2025 Pompeyo Curbelo   19.72 Dec 08, 2025 @ 21.65 +9.79%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SRPT Comments

Write your thoughts about Sarepta Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Boubou C
Boubou C Jun 16, 2025 12:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Holding 12 monts for guaranteed 100% profit.
Dave Schultz
Dave Schultz Jan 08, 2021 12:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Got in this is huge discount 🙌🏽👌🏼👌🏼
Shan Mirza
Shan Mirza Sep 19, 2020 14:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TMDI is a medical tech stock you should be loading up on, partnered with Medtronic!
Harry Singh
Harry Singh Dec 23, 2019 3:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
may go up today!!!
ritchie donaghue
ritchie donaghue Jul 03, 2019 10:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
finally taing hold since the last stock offering
Marty Nanasi
Marty Nanasi Sep 08, 2017 14:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is truly manipulated by MM and algo. Really surprising since it like clockwork.
Marty Nanasi
Marty Nanasi Sep 06, 2017 9:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Looking through the weeds on this one as it might be a ten bagger if executed launch properly in US and EU
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email